These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34997616)

  • 1. Methaemoglobinaemia and the radical curative efficacy of 8-aminoquinoline antimalarials.
    White NJ; Watson JA; Baird JK
    Br J Clin Pharmacol; 2022 Jun; 88(6):2657-2664. PubMed ID: 34997616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose tafenoquine for preventing relapse in people with plasmodium vivax malaria-an updated meta-analysis.
    Anjum MU; Naveed AK; Mahmood SN; Naveed OK
    Travel Med Infect Dis; 2020; 36():101576. PubMed ID: 32036012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafenoquine: First Global Approval.
    Frampton JE
    Drugs; 2018 Sep; 78(14):1517-1523. PubMed ID: 30229442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.
    Lacerda MVG; Llanos-Cuentas A; Krudsood S; Lon C; Saunders DL; Mohammed R; Yilma D; Batista Pereira D; Espino FEJ; Mia RZ; Chuquiyauri R; Val F; Casapía M; Monteiro WM; Brito MAM; Costa MRF; Buathong N; Noedl H; Diro E; Getie S; Wubie KM; Abdissa A; Zeynudin A; Abebe C; Tada MS; Brand F; Beck HP; Angus B; Duparc S; Kleim JP; Kellam LM; Rousell VM; Jones SW; Hardaker E; Mohamed K; Clover DD; Fletcher K; Breton JJ; Ugwuegbulam CO; Green JA; Koh GCKW
    N Engl J Med; 2019 Jan; 380(3):215-228. PubMed ID: 30650322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tafenoquine: A Step toward Malaria Elimination.
    Lu KY; Derbyshire ER
    Biochemistry; 2020 Mar; 59(8):911-920. PubMed ID: 32073254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PFMDR1 POLYMORPHISMS INFLUENCE ON IN VITRO SENSITIVITY OF THAI PLASMODIUM FALCIPARUM ISOLATES TO PRIMAQUINE, SITAMAQUINE AND TAFENOQUINE.
    Kaewpruk N; Tan-ariya P; Ward SA; Sitthichot N; Suwandittakul N; Mungthin M
    Southeast Asian J Trop Med Public Health; 2016 May; 47(3):366-76. PubMed ID: 27405118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tafenoquine and primaquine do not exhibit clinical neurologic signs associated with central nervous system lesions in the same manner as earlier 8-aminoquinolines.
    Berman J; Brown T; Dow G; Toovey S
    Malar J; 2018 Nov; 17(1):407. PubMed ID: 30400893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tafenoquine for the treatment of
    Llanos-Cuentas A; Manrrique P; Rosas-Aguirre A; Herrera S; Hsiang MS
    Expert Opin Pharmacother; 2022 May; 23(7):759-768. PubMed ID: 35379070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 8-Aminoquinoline Therapy for Latent Malaria.
    Baird JK
    Clin Microbiol Rev; 2019 Sep; 32(4):. PubMed ID: 31366609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific.
    Elmes NJ; Nasveld PE; Kitchener SJ; Kocisko DA; Edstein MD
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1095-101. PubMed ID: 18541280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
    Fukuda MM; Krudsood S; Mohamed K; Green JA; Warrasak S; Noedl H; Euswas A; Ittiverakul M; Buathong N; Sriwichai S; Miller RS; Ohrt C
    PLoS One; 2017; 12(11):e0187376. PubMed ID: 29121061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tafenoquine: a promising new antimalarial agent.
    Crockett M; Kain KC
    Expert Opin Investig Drugs; 2007 May; 16(5):705-15. PubMed ID: 17461742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of relapsing Plasmodium vivax malaria during pregnancy.
    Spiegelenberg JP; Bastiaens GJH; Hassing RJ
    J Travel Med; 2021 Jul; 28(5):. PubMed ID: 34104968
    [No Abstract]   [Full Text] [Related]  

  • 16. Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review.
    Duparc S; Chalon S; Miller S; Richardson N; Toovey S
    Malar J; 2020 Mar; 19(1):111. PubMed ID: 32169086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Historical 8-Aminoquinoline Combinations: Not All Antimalarial Drugs Work Well Together.
    Shanks GD
    Am J Trop Med Hyg; 2022 Nov; 107(5):964-967. PubMed ID: 36252799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Getting the blues at a rock concert: a case of severe methaemoglobinaemia.
    Wilkerson RG
    Emerg Med Australas; 2010 Oct; 22(5):466-9. PubMed ID: 21040486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the Antirelapse Efficacy of Tafenoquine, Using Plasmodium vivax Genotyping.
    Beck HP; Wampfler R; Carter N; Koh G; Osorio L; Rueangweerayut R; Krudsood S; Lacerda MV; Llanos-Cuentas A; Duparc S; Rubio JP; Green JA
    J Infect Dis; 2016 Mar; 213(5):794-9. PubMed ID: 26500351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cure.
    Srinivasan S; Roy D; Chavas TEJ; Vlaskin V; Ho DK; Pottenger A; LeGuyader CLM; Maktabi M; Strauch P; Jackson C; Flaherty SM; Lin H; Zhang J; Pybus B; Li Q; Huber HE; Burke PA; Wesche D; Rochford R; Stayton PS
    J Control Release; 2021 Mar; 331():213-227. PubMed ID: 33378692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.